Converge Bio Lands $25M to Replace Trial-and-Error Drug Discovery
Converge Bio Workforce What You Ought to Know – Converge Bio has introduced a $25M Sequence ...
Read more
Tag: 25M
Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapy
What You Ought to Know: – Onchilles Pharma, a non-public biotech firm pioneering next-generation cytotoxic therapeutics ...
Read more
Pleno Closes $25M Series B & Appoints Dr. Vik Vaz as CEO
Dr. Vik Vaz, CEO at Pleno What You Ought to Know: – Pleno, an progressive multi-omics ...
Read more
Synapticure Raises $25M to Expand Virtual Care for Neurodegenerative Diseases
What You Ought to Know: – Synapticure, a digital care firm centered on neurodegenerative ailments secures ...
Read more
